Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Dan Levitan on Maveron’s Bay Area Expansion, Its Latest Stealth Startup, and His First Starbucks
|
Gregory T. Huang |
11/19/09 |
Seattle
|
|
Good Things in Threes: Trius Therapeutics Files for IPO to Fund Phase 3 Clinical Trials, Marks San Diego’s Third IPO Filing
|
Bruce V. Bigelow |
11/09/09 |
San Diego
|
|
Wireless Chip Designer MaxLinear Files for IPO
|
Bruce V. Bigelow |
11/07/09 |
San Diego
|
|
Omeros, Worst Performing IPO of 2009, Casts Shadow Over Other Aspiring Biotechs
|
Luke Timmerman |
10/27/09 |
Seattle
|
|
STR Holdings Sets IPO Terms
|
Ryan McBride |
10/22/09 |
Boston
|
|
Top 10 Northwest Venture Deals of the Third Quarter—and VC Color Commentary
|
Gregory T. Huang |
10/20/09 |
Seattle
|
|
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/14/09 |
Seattle
|
|
Medical Device Startups Getting Squeezed by Recession, Lawmakers, Says E&Y Report
|
Luke Timmerman |
10/13/09 |
National
|
|
Omeros, First U.S. Biotech IPO Since February 2008, Sees Shares Drop 13 Percent in First Day
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Omeros Raises $68.2M in Washington’s First IPO in Two Years
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Amazon Goes Mobile, Theraclone Inks $18M Deal, Spiration Pulls In $7M, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/06/09 |
Seattle
|
|
On Verge of Omeros IPO, Former Finance Chief Accuses Company of Filing False Records with NIH
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
Omeros Teed Up for IPO Next Week, Seeking to Rake In More Than $80M
|
Luke Timmerman |
10/02/09 |
Seattle
|
|
A123Systems IPO Massively Exceeds Estimates
|
Ryan McBride |
09/24/09 |
Boston
|
|
Free & Clear Acquired for $100M-Plus, Calypso Gets $50M, Ensequence Ensnares $20M, & More Seattle-Area Deals News
|
Gregory T. Huang |
09/22/09 |
Seattle
|
|
Omeros Moves Closer to IPO, Zymo Drug Fails Arthritis Trials, Uptake Medical Gets $3.4M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/17/09 |
Seattle
|
|
Omeros Moves Closer To IPO, Sets Price Goal
|
Luke Timmerman |
09/16/09 |
Seattle
|
|
A Slice of the Seattle Blogosphere: OVP, IPOs, and Small Businesses
|
Gregory T. Huang |
09/04/09 |
Seattle
|
|
As Startup Considers IPO, Mission Ventures’ Leo Spiegel Sees End to San Diego’s VC Lockdown
|
Bruce V. Bigelow |
09/02/09 |
San Diego
|
|
Omeros Gets Ready for IPO, Cray Buys SiCortex Assets, ClearEdge Raises Cash, & More Seattle-Area Deals News
|
Gregory T. Huang |
09/01/09 |
Seattle
|
|
Of Phase Forward, MedVentive, and iMedX—Today’s New England Heath IT Deals Round-Up
|
Ryan McBride |
07/15/09 |
Boston
|
|
Elixir Raises $12 Million, Says Drug Trial Could Lead to Novartis Purchase
|
Roxanne Palmer |
05/19/09 |
Boston
|
|
Battery in $70M Round at ExactTarget
|
Ryan McBride |
05/07/09 |
Boston
|
|
Bridgepoint IPO Nets $142M
|
Juha-Pekka Tikka |
04/14/09 |
San Diego
|
|
Bridgepoint Files for Rare IPO
|
Bruce V. Bigelow |
04/02/09 |
San Diego
|
|
Big Drop in 1Q M&A Deals for VC-Backed Companies, IPO Drought Continues
|
Ryan McBride |
04/01/09 |
National
|
|
GlassHouse Nixes IPO
|
Wade Roush |
03/06/09 |
Boston
|
|
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News
|
Wade Roush |
12/24/08 |
Boston
|
|
Archemix Secures Partnership with Glaxo to Develop Drugs for Inflammatory Diseases
|
Luke Timmerman |
12/23/08 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
